In a landmark decision that will reshape how we approach obesity treatment worldwide, the World Health Organization1 has released its first-ever clinical guidelines recommending GLP-1 therapies for adults living with obesity. This isn’t merely another drug approval or incremental policy update; it represents a transformation in how the world’s leading health authority understands and addresses a condition affecting over 1 billion people globally.
Similar Posts
Creating Your Dream Garden Wedding: Tips and Tricks for a Memorable Celebration – Rosanna Davison Nutrition
A gorgeous garden space, with lush greenery and tranquil ambiance, can serve as the perfect setting…
Biogen, Sage Therapeutics Drop Plans to Develop Partnered Drug in Major Depressive Disorder
Biogen and Sage Therapeutics are discontinuing further development of their drug Zurzuvae as a potential treatment…
How Each mbg best skin+ Ingredient Benefits Aging Skin*
Hannah Frye is the Assistant Beauty Editor at mindbodygreen. She has a B.S. in journalism and…
Travel as Therapy: Why Austria—Especially Vienna—Heals the Soul
Travel isn’t just leisure—it’s medicine. In an age of burnout, overstimulation, and chronic work stress, travel…
You’re Not Using A Nail Concealer? Here’s Why You Should (& The Best Options)
Concealer, IMO, is the most versatile product in your makeup bag. A confection that can diffuse…
Refreshing Cold Brew Coffee Recipe
“Police work wouldn’t be possible without coffee,” Wallander said.“No work would be possible without coffee.”They pondered…
